Skip to main content
Back to Bpifrance

Bpifrance's Therapeutics Portfolio

Browse 14 Therapeutics companies funded by Bpifrance. See funding amounts, founder contacts, and investment details.

Therapeutics Companies
14
Total Funding in Therapeutics
$324.2M

Therapeutics Portfolio Companies (14)

Export
BiotechnologyTherapeutics

Carroucell is the microcarrier supplier for cell culture in bioreactor.

Sainte-hélène-du-lac, France
September 2022
$1.5M
Series A

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareLife ScienceTherapeutics

ImCheck Therapeutics designs and develops immunotherapeutic antibodies for the treatment of cancer and autoimmune disease.

Marseille, France
August 2024
$22.4M
Grant

Founder Contacts

30,000+ verified contacts

Child CareHealth CareTherapeutics

Ludocare is to create ways to provide assistance to patients and their families to improve their abilities, autonomy, and quality of life.

Lyon, France
July 2022
$4.4M
Seed

Founder Contacts

30,000+ verified contacts

BiotechnologyMedicalOncologyTherapeutics

Innovative peptides as targeted therapies for oncology

Évry, France
July 2021
$1.9M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyMedicalOncologyTherapeutics

Apmonia Therapeutics is a biotech company that develop therapeutic strategies towards multiple types of cancer.

Reims, France
July 2024
$7.6M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife ScienceTherapeutics

Ona Therapeutics develops antibody-drug conjugates and therapies for the treatment of advanced and treatment-resistant cancers.

Barcelona, Spain
June 2026
$86.6M
Series B

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyTherapeutics

TreeFrog Therapeutics is a stem cell company that will enable millions of patients to access the medical revolution of cell therapies.

Bordeaux, France
May 2025
$34.0M
Debt Financing

Founder Contacts

30,000+ verified contacts

MedicalNeuroscienceTherapeutics

Biodol Therapeutics made a breakthrough discovery on the origin and maintenance of NP.

Clapiers, France
May 2024
$7.6M
Undisclosed

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Aelis Farma is a biotech company that develops pharmaceutical therapies that target chronic and neurodegenerative diseases.

Bordeaux, France
April 2026
$528K
Grant

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Valneva focuses on the development and commercialization of prophylactic vaccines for infectious diseases.

Saint-herblain, France
April 2026
$43.1M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Adcendo is a biotech company that develops antibody-drug conjugates (ADCs) to target cancers with high unmet medical needs.

Copenhagen, Denmark
April 2026
$75.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife SciencePrecision MedicineTherapeutics

Odimma is a biotech company that focuses on precision medicine and cure for personalized cancer immunotherapy.

Illkirch-graffenstaden, France
April 2023
$2.0M
Seed

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareOncologyTherapeutics

Egle Therapeutics is a biotechnology company focused on developing immunotherapies for oncology and autoimmune diseases.

Paris, France
March 2026
$9.4M
Grant

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsTherapeutics

EG 427 is a French biotechnology company that pioneers a new approach in gene therapy called pinpoint gene therapy.

Paris, France
February 2025
$28.2M
Series B

Founder Contacts

30,000+ verified contacts

Explore Bpifrance's Full Portfolio

View all companies funded by Bpifrance across every industry and funding stage.

View Full Bpifrance Portfolio